Open AccessDistinct MRI pattern of “pseudoresponse” in recurrent glioblastoma multiforme treated with regorafenib: Case report and literature review
Author(s) -
Gatto Lidia,
Franceschi Enrico,
Tosoni Alicia,
Di Nunno Vincenzo,
Maggio Ilaria,
To Caterina,
Lodi Raffaele,
Agati Raffaele,
Bartolini Stefania,
Brandes Alba Ariela
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.4604
Subject(s) - glioblastoma , medicine , regorafenib , hyperintensity , magnetic resonance imaging , fluid attenuated inversion recovery , radiology , bevacizumab , gadolinium dtpa , pathology , cancer research , chemotherapy , cancer , colorectal cancer
Antiangiogenic agents can induce a distinct MRI pattern in glioblastoma, characterized by a decrease in the contrast enhancement on T1‐weighted images and a simultaneous hyperintensity on T2‐weighted or fluid‐attenuated inversion recovery images.